文献速递腹部技术与安全US

COVID-19住院患者胆道干预的预测因素

Predictors of biliary intervention in patients hospitalized for COVID-19.
PubMed 文献 · Abdom Radiol (NY) · 2022-03-02

结果显示,肝脏大小和住院期间利尿剂使用是两组间仅有的显著差异变量;控制利尿剂使用后,肝脏大小每增加1厘米,接受胆囊造瘘术的几率增加30%。

要点

  • COVID-19住院患者需胆道干预者常存在肝脏增大和利尿剂使用。
  • 肝脏大小每增加1厘米,胆囊造瘘术几率增加30%(p=0.03)。
  • ICU入住、机械通气、感染性休克等变量接近但未达统计学显著。

核心结论

  • COVID-19住院期间需要胆道干预的患者可能伴有肝脏增大形式的肝损伤,并需要使用利尿剂。

关键影像表现/征象

  • 肝脏大小和住院期间利尿剂使用是两组间仅有的显著差异变量(p值分别为0.02和0.046)。
  • 控制利尿剂使用后,肝脏大小每增加1厘米,接受胆囊造瘘术的几率增加30%(p=0.03)。
  • ICU入住(p=0.16)、机械通气(p=0.09)、感染性休克(p=0.08)、血清碱性磷酸酶水平(p=0.16)和门静脉通畅性(p=0.14)接近统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Gastrointestinal complications of coronavirus disease-2019 (COVID-19) include abnormal liver function and acalculous cholecystitis. Cholecystostomy performed during the COVID-19 pandemic reflected a shift toward non-surgical treatment of cholecystitis and increased number of critically ill patients suffering from acalculous cholecystitis.

PURPOSE: (1) To determine demographic, clinical, laboratory, and ultrasound features associated with cholecystostomy placement during hospitalization for COVID-19. (2) To develop multivariable logistic regression modeling for likelihood of biliary intervention.

METHODS: This retrospective review received institutional review board approval. Informed consent was waived. Between March 2020 and June 2020, patients with confirmed SARS-CoV2 infection admitted to New York-Presbyterian Hospital (NYP)/Weill Cornell Medical Center, NYP/Lower Manhattan Hospital, and NYP/Queens were evaluated for inclusion in this study. Inclusion criteria were (1) patient age ≥ 18, (2) confirmed COVID-19 infection by polymerase chain reaction testing of a nasopharyngeal swab, and (3) abdominal ultrasound performed during hospitalization. Exclusion criteria were (1) history of cholecystectomy and (2) biliary intervention performed prior to abdominal ultrasound. Patients were stratified into two groups based on whether they received cholecystostomy during hospitalization. Differences in demographics, medical history, clinical status, medications, laboratory values, and ultrasound findings between the two groups were evaluated using Chi-square test or Fisher's exact test for categorical variables and t test or Wilcoxon-rank sum test for continuous variables. Multivariable logistic regression was used to model likelihood of biliary intervention.

RESULTS: Nine patients underwent cholecystostomy placement and formed the "Intervention Group." 203 patients formed the "No Intervention Group." Liver size and diuretics use during hospitalization were the only variables which were significantly different between the two groups, with p-values of 0.02 and 0.046, respectively. After controlling for diuretics use, the odds of receiving cholecystostomy increased by 30% with every centimeter increase in liver size (p = 0.03). ICU admission approached significance (p = 0.16), as did mechanical ventilation (p = 0.09), septic shock (p = 0.08), serum alkaline phosphatase level (p = 0.16), and portal vein patency (0.14).

CONCLUSION: Patients requiring biliary intervention during hospital admission for COVID-19 were likely to harbor liver injury in the form of liver enlargement and require diuretics use.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Chen, Riyahi, Prince, et al. Predictors of biliary intervention in patients hospitalized for COVID-19. Abdom Radiol (NY). 2022. PMID: 35234995. doi:10.1007/s00261-022-03461-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。